| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
153,922,000 |
| Market
Cap: |
6.15(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$36.9 - $39.95 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile IVERIC bio is biopharmaceutical company focused on the discovery and development of treatments for retinal diseases with unmet medical needs. Co.'s clinical stage product candidate, Zimura® (avacincaptad pegol), a complement C5 inhibitor. Co. is targeting the following diseases with Zimura: Geographic Atrophy, intermediate age-related macular degeneration, and autosomal recessive Stargardt disease. In addition to Zimura, Co. is developing its preclinical product candidate IC-500, a high temperature requirement A serine peptidase 1 protein inhibitor, for GA and potentially other age-related retinal diseases.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
40,000 |
561,286 |
| Total Sell Value |
$0 |
$0 |
$1,546,400 |
$15,378,126 |
| Total People Sold |
0 |
0 |
1 |
5 |
| Total Sell Transactions |
0 |
0 |
2 |
30 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Westby Keith |
SVP & COO |
• – – |
2020-12-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
61,544 |
|
- |
|
| Sblendorio Glenn |
President and CEO |
• • – |
2020-12-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,750 |
250,823 |
|
- |
|
| Carroll David Francis |
SVP, CFO and Treasurer |
• – – |
2020-12-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
47,040 |
|
- |
|
| Guyer David R |
Executive Chairman |
• • – |
2020-12-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,813 |
71,785 |
|
- |
|
| Carroll David Francis |
SVP, CFO and Treasurer |
• – – |
2020-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
33,707 |
|
- |
|
| Versant Ventures Iv, Llc |
10% Owner |
– – • |
2020-06-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,484,100) |
0 |
|
- |
|
| Versant Ventures Iv, Llc |
10% Owner |
– – • |
2020-06-19 |
4 |
A |
$0.00 |
$0 |
I/I |
34,282 |
34,282 |
|
- |
|
| Sblendorio Glenn |
President and CEO |
• • – |
2020-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,750 |
225,061 |
|
- |
|
| Westby Keith |
SVP & COO |
• – – |
2020-01-06 |
4 |
S |
$8.07 |
$2,365 |
D/D |
(293) |
40,983 |
|
54% |
|
| Guyer David R |
Executive Chairman |
• • – |
2020-01-06 |
4 |
S |
$8.07 |
$27,172 |
D/D |
(3,367) |
53,972 |
|
54% |
|
| Westby Keith |
SVP & COO |
• – – |
2020-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
700 |
41,276 |
|
- |
|
| Guyer David R |
Executive Chairman |
• • – |
2020-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,250 |
57,339 |
|
- |
|
| Guyer David R |
Executive Chairman |
• • – |
2019-12-13 |
4 |
S |
$6.60 |
$61,215 |
D/D |
(9,275) |
51,089 |
|
- |
|
| Westby Keith |
SVP & COO |
• – – |
2019-12-13 |
4 |
S |
$6.60 |
$29,898 |
D/D |
(4,530) |
40,576 |
|
- |
|
| Carroll David Francis |
SVP, CFO and Treasurer |
• – – |
2019-12-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
26,207 |
|
- |
|
| Guyer David R |
Executive Chairman |
• • – |
2019-12-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,200 |
60,364 |
|
- |
|
| Sblendorio Glenn |
President and CEO |
• • – |
2019-12-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,950 |
199,804 |
|
- |
|
| Westby Keith |
SVP & COO |
• – – |
2019-12-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
45,106 |
|
- |
|
| Sblendorio Glenn |
President and CEO |
• • – |
2019-12-10 |
4 |
B |
$4.00 |
$250,000 |
D/D |
62,500 |
176,854 |
2.81 |
- |
|
| Sblendorio Glenn |
President and CEO |
• • – |
2019-11-15 |
4 |
B |
$3.12 |
$46,851 |
D/D |
15,000 |
114,354 |
2.81 |
- |
|
| Carroll David Francis |
SVP, CFO and Treasurer |
• – – |
2019-07-02 |
4 |
S |
$1.25 |
$3,466 |
D/D |
(2,773) |
13,707 |
|
- |
|
| Carroll David Francis |
SVP, CFO and Treasurer |
• – – |
2019-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
16,480 |
|
- |
|
| Sblendorio Glenn |
President and CEO |
• • – |
2019-05-10 |
4 |
B |
$1.48 |
$37,000 |
D/D |
25,000 |
93,105 |
2.81 |
- |
|
| Sblendorio Glenn |
President and CEO |
• • – |
2019-04-02 |
4 |
S |
$1.43 |
$9,887 |
D/D |
(6,914) |
68,105 |
|
- |
|
| Sblendorio Glenn |
President and CEO |
• • – |
2019-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,750 |
75,019 |
|
- |
|
468 Records found
|
|
Page 8 of 19 |
|
|
